
Glycoaish 0.2mg Injection
Marketer
Aishwarya Healthcare
Salt Composition
Glycopyrrolate (0.2mg)
Overview Glycoaish 0.2mg Injection
Glycoaish 0.2mg Injection, an anticholinergic agent, is administered pre- or intra-operatively to suppress secretions and counteract the effects of certain surgical adjuvants, such as muscle relaxants. It also offers therapeutic benefit in peptic ulcer management when oral administration is unsuitable. Administration is solely by a qualified medical professional. Complete disclosure of all concurrent medications is crucial, due to potential interactions. Discontinuing treatment prematurely may lead to symptom recurrence and disease exacerbation; therefore, adhere strictly to the prescribed duration. Common adverse reactions include xerostomia, urinary retention, blurred vision, photosensitivity, mydriasis, cycloplegia, tachycardia, elevated intraocular pressure, bradycardia, palpitations, and diminished perspiration. Alcohol consumption should be avoided due to potential synergistic sedative effects. Prior to treatment, inform your physician of any pre-existing glaucoma, myasthenia gravis, cardiac insufficiency, or hypertension.
Uses of Glycoaish 0.2mg Injection
Surgical Anesthesia | Gastric Ulceration
Major Benefits of Glycoaish 0.2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Glycoaish 0.2mg Injection:
- Urinary retention
- Blurred vision
- Dilatation of pupil
- Cycloplegia (paralysis of the ciliary muscle of the eye)
- Ocular hyperemia
- Slow heart rate
- Palpitations
- Reduced sweating
- Increased heart rate
- Increased intraocular pressure
How to use Glycoaish 0.2mg Injection:
Administering this medication will be handled by your physician or registered nurse; patient self-administration is strictly prohibited.
How Glycoaish 0.2mg Injection works:
Glycoaish 0.2mg Injection, an anticholinergic agent, inhibits the action of acetylcholine, a neurotransmitter, within the central nervous system.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Glycoaish 0.2mg Injection may pose safety risks; physician consultation is advised.
PregnancySAFE IF PRESCRIBED
The injectable formulation Glycoaish 0.2mg is generally deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Glycoaish 0.2mg Injection appears safe for breastfeeding mothers. Available human data indicates minimal infant risk. However, prolonged Glycoaish 0.2mg Injection use may decrease breast milk supply.
DrivingUNSAFE
Glycoaish 0.2mg Injection can induce adverse reactions that might impair driving capabilities. These reactions may include visual disturbances and impaired coordination, potentially affecting safe driving.
KidneyCAUTION
Administering Glycoaish 0.2mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification of Glycoaish 0.2mg Injection might be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Glycoaish 0.2mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Glycoaish 0.2mg Injection :
NA
Facts to Know About Glycoaish 0.2mg Injection
| Label | Value |
|---|---|
| Type of Compound | Man-made quaternary ammonium compounds |
| Addiction potential | None. |
| Medication Classification | Stomach and bowel |
| Mechanism of Action | Antimuscarinic - Surgical Anesthesia |
